Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
BRIDG Standard Development Research Initiative FDA NCI Developing a conceptual data model that harmonize EMR data and protocol driven data
Bridge to Artificial Intelligence (Bridge2AI) Research Initiative FDA OD/DPCPSI/OSC, NLM, NEI, NHGRI, NCCIH, NIBIB, NICHD, NCATS, NIMH, NIMHD, NIAID, NCI, NIAMS, NINDS, NIDA, NIA, NIGMS, FIC, OD/DPCPSI/OBSSR, OD/AoU, OD/DPCPSI/ODSS The Bridge to Artificial Intelligence (Bridge2AI) program seeks to propel biomedical research forward by setting the stage for widespread adoption of artificial intelligence (AI) and machine learning (ML) that tackles complex biomedical challenges beyond human intuition. Bridge2AI works with representatives from the Defense Advanced Research Projects Agency (DARPA), U.S. Department of Energy (DOE), National Science Foundation (NSF), National Institute of Standards and Technology (NIST), and U.S. Food and Drug Administration (FDA) in order to bring expertise from across the federal government to help develop this groundbreaking new program that aims to harness the power of AI/ML for human health. Bridge2AI is also collaborating with DOE Office of Science program in Advanced Scientific Computing Research to jointly address important issues and challenges in developing AI and machine learning methods for privacy-sensitive datasets.
Build UP Trust Challenge Prize Resource Development CDC, HRSA, OASH NHLBI, NIMHD, NCI, NIA, NIAID, NIEHS, NINDS, NCATS, NIAMS, NIBIB, NIDA, NICHD The major objective of the Build UP Trust Challenge is to increase research participation, adoption of existing and new tools and strategies to detect, treat, and monitor diseases and disorders by improving engagement with underserved populations.
Canadian - U.S. Dietary Reference Intakes Working Group Committee, Work group, Advisory group, or Task Force AHRQ, CDC, FDA, OASH OD/DPCPSI/ONR, NIDDK, OD/DPCPSI The US and Canadian governments have each established Federal DRI Committees that work collaboratively to identify DRI needs and to coordinate government sponsorship of DRI reviews and related activities. The DRIs — which reflect nutrient reference values essential to national nutrition policies and to professionals working in the field of nutrition and health — have been developed under the auspices of the Institute of Medicine with funding from the US and Canadian governments.
Cancer Diagnostic Devices Interagency Task Force (CD2) - MOU among NCI, FDA, HRSA Committee, Work group, Advisory group, or Task Force FDA, HRSA NCI On Friday, September 17, 2021, leadership from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Health Resources and Services Administration (HRSA) signed a Memorandum of Understanding (MOU) to support solutions for early cancer detection and diagnosis to improve patient outcomes, quality of life, and reduce health disparities among medically underserved, geographically isolated, and otherwise vulnerable populations. MOU formalizes the establishment of a new interagency task force, the Cancer Diagnostic Devices Interagency Task Force (CD2), which includes representatives from the NCI, FDA, and HRSA.
Cancer Moonshot Award Research Initiative OS NIDCD, NCI Cancer Moonshot Award to discover a panel of TCRs with various HLA restrictions for cancer and otolaryngic infectious disorders
CCDI Molecular Target Platform Resource Development FDA NCI The CCDI Molecular Targets Platform allows users to browse and identify associations between molecular targets, diseases, and drugs.
CDC Acute Flaccid Myelitis Task Force Committee, Work group, Advisory group, or Task Force CDC NINDS, NIAID The AFM Task Force was established to aid in the ongoing investigation to define the cause of, and improve treatment and outcomes for, patients with AFM. The Task Force functions as a work group of the CDC Board of Scientific Counselors, Deputy Director for Infectious Diseases.
CDC Integration with GrantSolutions Resource Development ACF, CDC OD/OER Collaboration with GrantSolutions to allow the Centers for Disease Control and Prevention (CDC) Research programs to seamlessly use electronic Research Administration (eRA) research grant support services, including the eRA Commons grantee portal and the eRA Peer Review suite while having grants management staff process awards within GrantSolutions.
CDC Office of Public Health Genomics Public Education Campaign CDC NHLBI This collaboration seeks to define and implement a translational trajectory for scientific discoveries in genomics and related fields to population health benefits in health areas relevant to National Heart, Lung, and Blood Institute (NHLBI) including, heart, lung, blood, and sleep disorders.